Möchten Sie immer auf dem neuesten Stand bleiben?

— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune...

Ra’anana, Israel, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize...

HONKARAKENNE OYJ        HALF YEAR REPORT                 22 AUGUST 2025 AT 9:00 HONKARAKENNE OYJ HALF-YEAR REPORT 1 JANUARY TO 30 JUNE 2025 NET SALES IN GROWTH, OPERATING PROFIT AT THE PREVIOUS...

Chicago, Aug. 20, 2025 (GLOBE NEWSWIRE) -- The global digital health in neurology market was valued at US$ 38.9 billion in 2024 and is expected to reach US$ 229.5 billion by 2033, growing at a CAGR...

Chicago, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global advanced ophthalmology technology market was valued at US$ 8.78 billion in 2024 and is expected to reach US$ 16.01 billion by 2033, growing at a...

NESS ZIONA, Israel, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today reported...

Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates

TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the...

-  Gained alignment with U.S. Food and Drug Administration (FDA) on the ongoing Phase 2 AQUAx2 randomized double-blind, placebo-controlled pivotal study in Grade 2/3 radiation-induced xerostomia (RIX)...

Marimekko Corporation, Half-year Financial Report, 14 August 2025 at 8.00 a.m. EEST HALF-YEAR FINANCIAL REPORT OF MARIMEKKO CORPORATION, 1 January–30 June 2025: Marimekko’s net sales in the second...